Sinovac Receives $9.6 Million Grant to Build E71 Vaccine Facility

Sinovac Biotech will receive a $9.6 million grant to build a production facility for its Enterovirus 71 vaccine against hand foot and mouth disease (HFMD). The company said the grant was a response to epidemic levels of HFMD in China and the government's desire to develop China biotech. Sinovac must use the money to complete construction of its GMP-compliant production facility, which will have an annual capacity of 20 million doses of EV71 vaccine, and to commercialize the vaccine in China. More details.... Stock Symbol: (NSDQ: SVA) Share this with colleagues: // //